This week I moderated a webinar at the Food & Drug Law Institute (FDLI) on the regulation of cannabis-derived products. This is a product & policy area that’s evolving as I type. Just this week, former FDA Commissioner Scott Gottlieb wrote an op-ed acknowledging the consumer “craze” for products with CBD in them and encouraging FDA […]
Following up on my post about a Congressional hearing on regulatory reform before the U.S. Senate Committee on Homeland Security and Governmental Affairs Subcommittee on Regulatory Affairs and Federal Management (RAFM), two new bills were introduced on May 13. Both bills grew out of that hearing (video & written testimony available on the HSGAC website). The Early […]
The REINS Act would have required Congress to approve all new “major” rules before they could go into effect. A significant re-ordering of the regulatory process, it was one of many regulatory reform bills that was introduced but not enacted in the 115th Congress. The REINS Act reflected aspects of a larger movement to strengthen the […]
Two former OIRA Administrators are testifying tomorrow morning in a hearing that might re-kindle regulatory reform efforts in Congress. As Chris Walker has covered on this blog, the 115th Congress had a flurry of regulatory reform activity, none of which was enacted. This is the first Senate hearing in the 116th to take up regulatory reform.* […]
In mid-May, the GW Regulatory Studies Center will host UVA Professor Rachel A. Potter to discuss her new book “Bending the Rules: Procedural Politicking in the Bureaucracy.” From the University of Chicago Press summary: “With Bending the Rules, Rachel Augustine Potter shows that rulemaking is not the rote administrative activity it is commonly imagined to be but […]
The Office of Management and Budget issued a memo on Thursday describing its new approach to its implementation of the Congressional Review Act (CRA). Under the CRA, the Office of Information and Regulatory Affairs (OIRA) is required to determine whether agency “rules” are “major.” In this memo, OMB calls for information about economic impacts to inform its […]
I’m following Professor Aaron Nielson’s (BYU) lead and sharing an abbreviated summary of my remarks from the recent & excellent day-long Yale Journal on Regulation conference on “Regulatory Change & the Trump Administrative State.” I was delighted to be part of the panel on “Changes in Administrative Law in the Executive Branch,” along with Professors […]
There was a big development in the litigation challenging Trump’s regulatory “two-for-one” executive order last night. As I blogged about earlier, Judge Moss previously dismissed the case for lack of standing on February 26, 2018. Plaintiffs requested the ability to amend their complaint in light of the opinion, which the government did not oppose. That second […]
The longest shutdown in the history of the federal government ended yesterday. It lasted 35 days. It was a partial shutdown, but its effects unfold for months, if not longer. While I was trolling around on various .gov websites (dear reader, do I need better hobbies? I think we both know the answer is “no”), […]
I have a piece up in The Hill with some initial thoughts about 5 ways the partial federal shutdown is playing out in the rulemaking process. The punchline is that the longer key aspects of the federal regulatory process remain idle, the harder it will be for the president to make progress on his deregulatory goals. […]
Over at SCOTUSblog, health law and admin law dynamos Abbe R. Gluck and Anne Joseph O’Connell joined forces to write a helpful argument preview for a case that will be argued at the Supreme Court next week. Azar v. Allina Health Services is both a Medicare case and an interpretive rule case; a complexity two-fer, if […]
Earlier this week I posted a new report over at the GW Regulatory Studies Center that sheds some light on the inner workings of this administration’s ongoing regulatory two-for-one initiative. As you might recall, Executive Order 13771 imposed new constraints on executive branch regulatory agencies, directing them to cut two rules for any new rule issued and to […]
Earlier this month the U.S. Department of Labor (DOL) issued a proposed rule that may turn out to be the first opportunity to test the Congressional Review Act (CRA) post-disapproval restriction on rulemaking. The CRA authorizes Congress to use an expedited process to nullify recent rules. It has been used successfully 17 times, 16 of which […]
Last year, Chris Walker shared a heads up about a series hosted by the Brookings Center on Regulation and Markets on Regulatory Process and Perspective. The series has developed really nicely, offering a data-driven insights in this important field. A few recent highlights that I keep coming back to for reference: Trump’s deregulatory efforts keep […]
It’s a big day for folks who follow regulation! The Unified Agenda of Regulatory (and Deregulatory) Actions for Fall 2018 rolled out today along with a report on the FY 2018 results of the President’s regulatory two-for-one initiative. These are important documents because, respectively, they give us a snapshot of the government’s plans for the next […]